OBSOLETE: Vitiligo-associated autoimmune disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:247871
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Vitiligo-associated autoimmune disease refers to a group of autoimmune conditions that tend to occur together with vitiligo, a skin condition where patches of skin lose their color (pigment). This entry in medical databases has been marked as 'OBSOLETE,' meaning it is no longer used as a standalone diagnosis. Instead, the individual conditions that make up this grouping are now classified separately. Vitiligo itself is a condition where the immune system mistakenly attacks the melanocytes — the cells that give skin its color — leading to white patches on the skin. People with vitiligo have a higher-than-average chance of developing other autoimmune diseases, including autoimmune thyroid disease (such as Hashimoto's thyroiditis or Graves' disease), type 1 diabetes, pernicious anemia, Addison's disease, rheumatoid arthritis, and alopecia areata (patchy hair loss). This clustering of autoimmune conditions suggests shared genetic and immune system factors. Treatment focuses on managing each individual autoimmune condition. For vitiligo itself, treatments include topical creams, light therapy, and newer targeted medications. Because this term is obsolete, patients are encouraged to seek information under the specific autoimmune conditions they have been diagnosed with.

Key symptoms:

White or light patches on the skinLoss of skin color, especially on the face, hands, and around body openingsPremature graying of hair on the scalp, eyebrows, or eyelashesFatigue and tirednessUnexplained weight changesFeeling cold or heat intolerantPatchy hair lossTingling or numbness in hands and feetJoint pain or stiffnessIncreased thirst and frequent urinationDizziness or lightheadednessDifficulty concentrating or brain fogDry skin

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Vitiligo-associated autoimmune disease.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Vitiligo-associated autoimmune disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Vitiligo-associated autoimmune disease community →

No specialists are currently listed for OBSOLETE: Vitiligo-associated autoimmune disease.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Vitiligo-associated autoimmune disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Vitiligo-associated autoimmune diseaseForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Vitiligo-associated autoimmune disease.

Start the conversation →

Latest news about OBSOLETE: Vitiligo-associated autoimmune disease

No recent news articles for OBSOLETE: Vitiligo-associated autoimmune disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Should I be screened for other autoimmune conditions, and how often?,What treatment options are best for my specific pattern of vitiligo?,Are my family members at increased risk, and should they be tested?,What are the signs that a new autoimmune condition may be developing?,Is ruxolitinib cream (Opzelura) or phototherapy a good option for me?,How can I protect my mental health while managing these conditions?,What emergency situations should I be prepared for, and what should I do?

Common questions about OBSOLETE: Vitiligo-associated autoimmune disease

What is OBSOLETE: Vitiligo-associated autoimmune disease?

Vitiligo-associated autoimmune disease refers to a group of autoimmune conditions that tend to occur together with vitiligo, a skin condition where patches of skin lose their color (pigment). This entry in medical databases has been marked as 'OBSOLETE,' meaning it is no longer used as a standalone diagnosis. Instead, the individual conditions that make up this grouping are now classified separately. Vitiligo itself is a condition where the immune system mistakenly attacks the melanocytes — the cells that give skin its color — leading to white patches on the skin. People with vitiligo have a h

How is OBSOLETE: Vitiligo-associated autoimmune disease inherited?

OBSOLETE: Vitiligo-associated autoimmune disease follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.